AKT1 and neoplasm: A significant reduction in the levels of c-Myc, PDHK1, and LDHA as well as the phosphorylation of PI3K, AKT, mTOR (Wang P. et al., 2022), and p70S6K in tumor tissues, inhibiting c-Myc-mediated metabolic reprogramming have been reported.